Back to Search
Start Over
Reduction of QTc Dispersion by the Angiotensin II Receptor Blocker Valsartan May Be Related to Its Anti-Oxidative Stress Effect in Patients with Essential Hypertension
- Source :
- Hypertension Research. 30:307-313
- Publication Year :
- 2007
- Publisher :
- Japanese Society of Hypertension, 2007.
-
Abstract
- QT dispersion has been reported to increase in patients with essential hypertension, and abnormal QT dispersion is associated with arrythmias and sudden cardiac death. However, whether change in QT dispersion is related to oxidative stress is unclear. We examined the effect of the angiotensin II receptor blocker valsartan on QT dispersion and the relationship between oxidative stress and QT dispersion in patients with essential hypertension. Hypertensive patients whose systolic blood pressure (SBP) was more than 140 mmHg and/or diastolic blood pressure (DBP) was more than 90 mmHg were treated with valsartan. Blood pressure was measured once a month for 6 months. The difference between the maximal and minimal QT intervals within a 12-lead surface ECG was measured and QT dispersion and QTc dispersion corrected by heart rate were obtained before and 6 months after treatment. Left ventricular mass (LVM) assessed by echocardiography was obtained at baseline and 6 months after treatment. Venous blood samples were obtained at baseline and 6 months after treatment to measure serum levels of lipoperoxidation (LPO) and type I and III procollagen. Treatment with valsartan significantly decreased SBP and DBP. QTc dispersion decreased significantly 6 months after treatment with valsartan as compared to the baseline values. Valsartan treatment did not affect the LVM. Valsartan significantly decreased the abnormally high LPO levels. The changes in QTc dispersion were positively correlated with changes in the serum levels of LPO and with changes in DBP. The correlation between changes in LPO and QTc dispersion was more close than that between changes in DBP and QTc dispersion. In conclusion, antihypertensive therapy with valsartan reduces QTc dispersion and this may be related to the ability of valsartan to reduce oxidative stress in patients with essential hypertension.
- Subjects :
- Male
medicine.medical_specialty
Angiotensin receptor
Physiology
Tetrazoles
Blood Pressure
medicine.disease_cause
Essential hypertension
Collagen Type I
Sudden cardiac death
Electrocardiography
Heart Rate
Internal medicine
Heart rate
Internal Medicine
Humans
Medicine
Prospective Studies
cardiovascular diseases
Antihypertensive Agents
Aged
business.industry
Valine
Venous blood
medicine.disease
Long QT Syndrome
Oxidative Stress
Collagen Type III
Blood pressure
Valsartan
Hypertension
Cardiology
Female
Hypertrophy, Left Ventricular
Lipid Peroxidation
Cardiology and Cardiovascular Medicine
business
Angiotensin II Type 1 Receptor Blockers
Oxidative stress
Follow-Up Studies
circulatory and respiratory physiology
medicine.drug
Subjects
Details
- ISSN :
- 13484214 and 09169636
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Hypertension Research
- Accession number :
- edsair.doi.dedup.....1e3fbeb25db42ac7aeedccf54bd5f55f
- Full Text :
- https://doi.org/10.1291/hypres.30.307